Horizon Europe: Cluster 1 Health 2027 Call 01 – single stage

Overview for HORIZON-HLTH-2027-01

This call includes some of the single-stage topics of the 2027 Cluster Health Calls. All topics are described in detail in the entire work programme (content, budget, formal criteria, etc.).

This call opens officially on the 10 February 2027.

What can be funded?

All details about the current calls can be found here “Funding & tender opportunities” portal of the European Commission „Funding & tender opportunities“- Portal of the European Commission.

DESTINATION – STAYING HEALTHY IN A RAPIDLY CHANGING SOCIETY

  • HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion

DESTINATION – LIVING AND WORKING IN A HEALTH-PROMOTING ENVIRONMENT

  • HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
  • HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change

DESTINATION - TACKLING DISEASES AND REDUCING DISEASE BURDEN

  • HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
  • HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
  • HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
  • HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
  • HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)

DESTINATION - ENSURING EQUAL ACCESS TO INNOVATIVE, SUSTAINABLE, AND HIGH-QUALITY HEALTHCARE

  • HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

DESTINATION - MAINTAINING AN INNOVATIVE, SUSTAINABLE, AND COMPETITIVE EU HEALTH INDUSTRY  

  • HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals

Who can be funded?

Funding is available for European consortia consisting of several (usually at least 3) organisations from 3 countries; please refer to the European Commission's call for proposals documents.

What is the amount of funding?

Individual project funding depends on the topic. A budget of 342 million Euro is available for this call for proposals. Some call topics use lump sum funding.

What are the submission criteria?

The submission criteria are described in the European Commission's call documents.

How does the submission work?

Project applications must be submitted electronically via the European Commission's Funding & Tenders Portal.

When will a decision be made?

The results of the evaluations are expected in September 2027.

Further offers

43 Results
Selected filters
OpenX

About the FFG

The Austrian Research Promotion Agency (FFG) is the national funding institution for industry-related research and development in Austria. FFG funding plays a key role in generating new knowledge, developing new products and services, and thereby becoming more competitive in the global market.
Learn more

Stay connected

Every week, you will receive an update from the FFG in your inbox. Of course, you can unsubscribe from our newsletter at any time.